← Open Payments lookup

LAMONT DAVIS: Open Payments

NPI 1215271481 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$876 in 37 payments from 10 companies in 2025. Trend: 2023 $813 · 2024 $900 · 2025 $876

Food & beverage: $876
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation16$255
Medtronic, Inc.4$198
Merck Sharp & Dohme LLC6$127
ABIOMED1$101
PFIZER INC.3$60
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)2$37
CVRx, Inc.2$35
Amgen Inc.1$26
Bayer Healthcare Pharmaceuticals Inc.1$22
Alnylam Pharmaceuticals Inc.1$16

Products named: LEQVIO, AFFERA MAPPING SYSTEM, VERQUVO, ELIQUIS, PULSESELECT, LifeVest, Barostim Neo System, REPATHA.

Industry payments across TX — which companies pay providers there.